Reducing Hospital-acquired Pressure Injuries Among Pediatric Patients Receiving ECMO: A Retrospective Study Examining Quality Improvement Outcomes

• Published in: Wound management & prevention 2021-09, Vol.67 (9), p.14-24
• Main Authors: Jackson, Jordan E, Kirkland-Kyhn, Holly, Kenny, Laura, Beres, Alana L, Mateev, Stephanie
• Format: Article
• Language: English
• Subjects: Child; Extracorporeal Membrane Oxygenation - adverse effects; Hospitals; Humans; Infant; Infant, Newborn; Pressure Ulcer - epidemiology; Pressure Ulcer - etiology; Pressure Ulcer - prevention & control; Quality Improvement; Retrospective Studies
• ISSN: 2640-5237; 2640-5245
• DOI: 10.25270/wmp.2021.9.1424

Pediatric patients immobilized for certain procedures, such as extracorporeal membrane oxygenation (ECMO), are at high risk for developing hospital-acquired pressure injuries (HAPIs). To evaluate the rate of HAPI occurrence in ECMO patients before and after implementation of prevention interventions. Patients younger than 18 years of age who were placed on ECMO from January 2012 through March 2020 were identified, and patient data, including the development of a stage 3, 4, or unstageable pressure injuries, were abstracted. From August 2018 through December 2018, HAPI prevention interventions were implemented, which included targeted HAPI prevention and ECMO provider education, fluidized positioner provider education, and the addition of 2 wound care interventions for ECMO patients. Of the 120 ECMO patients identified, 5 (4.2%) developed a HAPI. All patients developed HAPI in the occipital region, and 1 patient developed an additional HAPI on their back. The median age of patients with HAPI was 1 month (interquartile range [IQR], 0.3-6.8 months). The median duration from ECMO cannulation to identification of HAPI was 9.5 days (IQR, 4.8-32.3 days). The median total run time was 4.9 days (IQR, 2.5-7.6 days): 8.5 days for patients who did develop a HAPI and 4.8 days for those who did not develop a HAPI (P = .02). The overall HAPI rate dropped from 4.8% of ECMO patients before quality improvement interventions to 0% of ECMO patients after quality improvement interventions. The development of stage 3, 4, or unstageable HAPIs in pediatric ECMO patients was low (4.2%) over the period studied (January 2012 through March 2020). As of the time of this writing, no HAPIs occurred after implementation of provider education in 2018.